Applying AI to Melanoma Detection
5 July 2018 In Prevention, Science
Is AI the future of detecting melanoma early, when it is easiest to cure?
Join the Ready. Raise. Rise. Pic Your Power Challenge!
20 June 2018 In Allies & Partnerships
We're thrilled to let you know that we are participating in Ready. Raise. Rise., a campaign sponsored by Bristol-Myers Squibb to raise awareness of immunotherapy (sometimes called immuno-oncology) research, including the emerging area of biomarkers. This year, Ready. Raise. Rise. is introducing the Pic Your Power challenge and we hope that you'll take part!
Making the Most Out of Immunotherapy
11 June 2018 In Science, Treatment
Learn what MRA-funded investigators are doing to optimize immunotherapy for patients.
We’ve Teamed Up with the American Cancer Society
By Cody R. Barnett, MRA Director of Communications | 7 June 2018 In Allies & Partnerships, Science, Treatment
American Cancer Society and Melanoma Research Alliance have united to fund lifesaving research aimed at reducing side effects and improving outcomes for patients treated with immunotherapy.
In Loving Memory of Rusty Cline
4 June 2018 In Melanoma Stories
Late last month we received word that Rusty Cline, an inspiring advocate and part of the MRA family, succumbed to melanoma after his diagnosis in 2006.
Why it Matters: U.S. Preventive Services Task Force Endorses Skin Cancer Prevention Counseling for Children and Young Adults
By Cody R. Barnett, MRA Director of Communications | 20 May 2018 In News, Prevention
This government-backed panel just put skin cancer prevention counseling on the map.
American Cancer Society and Melanoma Research Alliance Fund Five Innovative Approaches to Reduce Immunotherapy Side Effects
10 May 2018 In Allies & Partnerships, Science
As the world marks Melanoma Awareness Month, the American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) selected the first group of scientists to receive newly established research grants to investigate how to reduce rare, but serious, side effects resulting from cancer treatments with checkpoint inhibitors, a type of immunotherapy.
Melanoma Awareness Month: Opportunities to Make a Difference
By Cody R. Barnett, MRA Director of Communications | 30 April 2018 In Prevention
Melanoma Awareness Month, held in May each year, is a wonderful opportunity to raise awareness of the dangers of melanoma, the importance of early detection, and the many ways to practice sun safety. From talking about sun safety to your friends and family, taking the Skin Check Pledge, posting about melanoma on social media, or highlighting prevention strategies in your organization newsletter—there are many ways we can all take part and make a difference!
Tackling Brain Metastases
30 April 2018 In Science, Treatment
Brain metastases (mets) are a frequent and often deadly problem in patients with advanced melanoma. Nearly 40% of patients with metastatic melanoma have brain mets at diagnosis, with an average survival of only 4 months, suggesting a crucial need for treatments that can rid the brain of these tumors1,2. But new cancer treatments are rarely tested in patients with active brain mets. This is largely due to concerns about whether these patients will have side effects unique to brain mets, and poorer outcomes that may negatively weigh against otherwise positive clinical benefits. Another potential concern is whether the drugs will even penetrate the brain, which has a fortress-like ability to keep substances from entering it.
Take the Skin Check Pledge
By Cody R. Barnett, MRA Director of Communications | 30 April 2018 In Allies & Partnerships, Prevention
MRA and L'Oréal Paris challenge you to take the Skin Check Pledge.For each person who takes the skin check pledge, L'Oréal Paris has committed $100 per sign up, up to $250,000 for 2018. L'Oréal Paris is a featured partner of the Melanoma Research Alliance, committed to supporting research.